Challenges in stem cell-derived islet replacement therapy can be overcome
In this Commentary, we echo the conclusions of a recent review titled “ The promise of stem cell-derived islet replacement therapy ,” which highlighted recent advances in producing glucose responsive “islets” from stem cells and the benefits of their use in islet transplant therapy in type 1 diabete...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2021-09-01
|
| Series: | Cell Transplantation |
| Online Access: | https://doi.org/10.1177/09636897211045320 |
| Summary: | In this Commentary, we echo the conclusions of a recent review titled “ The promise of stem cell-derived islet replacement therapy ,” which highlighted recent advances in producing glucose responsive “islets” from stem cells and the benefits of their use in islet transplant therapy in type 1 diabetes (T1D). The review also outlined the status of clinical islet transplantation and the challenges that have prevented it from reaching its full therapeutic promise. We agree with the conclusions of the review and suggest that the identified challenges may be overcome by using the eye anterior chamber as an islet transplant site. We anticipate that the combination of stem cell-derived islets and intraocular transplant could help this promising T1D therapy reach full fruition. |
|---|---|
| ISSN: | 1555-3892 |